Mergers And Acquisitions News

The latest mergers and acquisitions stories, each synthesized from multiple sources with added background and context.

More Mergers And Acquisitions Stories

4D Molecular Therapeutics expands portfolio with acquisition of eye disease asset.
mergers-and-acquisitions3 years ago

4D Molecular Therapeutics expands portfolio with acquisition of eye disease asset.

4D Molecular Therapeutics has acquired the rights to the short-form human complement factor H (sCFH) asset from Aevitas Therapeutics, a subsidiary of Fortress Biotech. Meanwhile, Boehringer Ingelheim has inaugurated a new Germany-based research center, into which the company invested €350 million, to strengthen its biopharmaceuticals development. Additionally, Eli Lilly is planning to start testing its weight loss treatment candidate in a head-to-head clinical trial against Novo Nordisk’s Wegovy this month.